Thank you for your interest in the RESET-RA study. 

Based on your responses and your medication history, you do not meet the eligibility for this study at this moment. Participation in this study requires that you are on a stable dose of a conventional RA drugs, called DMARDs, such as methotrexate, hydroxychloroquine, leflunomide, or sulfasalazine for at least three months prior to participating in the study.

If yes, we encourage you to discuss your treatment options with your current rheumatologist and share your interest in participation in the RESET-RA study.  If you decide, in discussion with your current rheumalogist to initiate one of the drugs mentioned above, you can come back to the website and complete the questionnaire to see if you qualify at that time.

Please click here to view and print study information that you can share with your doctor. With your permission, we can also email you this information.

Disclaimer: The above is not diagnostic or treatment advice. Please talk to your physician about your treatment options.

Great, thank you!

Please read and acknowledge the disclosure below related to our privacy policy to give us permission to collect your contact information and send you information about this study.